Flynn James E

EDGAR CIK 0001352546

ARS Pharmaceuticals, Inc. - SPRY

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
4
($18.74) M
-1,021,784 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/27/2025
07/01/2025
Sell
-370,075 @ $18.46
 ($6,831,584) 4,887,254 (-7.04%) Indirect - Through Deerfield Private Design Fund III, L.P.
06/27/2025
07/01/2025
Sell
-370,074 @ $18.46
 ($6,831,566) 4,887,254 (-7.04%) Indirect - Through Deerfield Private Design Fund IV, L.P.
11/12/2024
11/13/2024
Sell
-17,407 @ $17.49
 ($304,532) 5,257,329 (-0.33%) Indirect - Through Deerfield Private Design Fund III, L.P.
11/11/2024
11/13/2024
Sell
-264,228 @ $18.04
 ($4,767,321) 5,274,736 (-4.77%) Indirect - Through Deerfield Private Design Fund III, L.P.

Nuvalent, Inc. - NUVL

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner Other owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($97.75) M
-1,000,000 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/22/2024
10/24/2024
Sell
-1,000,000 @ $97.75
 ($97,750,000) 8,670,512 (-10.34%) Indirect - Through Deerfield Private Design Fund IV, L.P.